Johnson & Johnson (JNJ)
275.38
+4.19
(+1.55%)
USD |
NYSE |
Sep 02, 16:00
275.51
+0.13
(+0.05%)
After-Hours: 17:49
Johnson & Johnson Research and Development Expense (TTM) : 15.06B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.06B |
| March 31, 2026 | 14.99B |
| December 31, 2025 | 14.72B |
| September 30, 2025 | 15.77B |
| June 30, 2025 | 17.03B |
| March 31, 2025 | 16.94B |
| December 31, 2024 | 17.26B |
| September 30, 2024 | 16.42B |
| June 30, 2024 | 14.91B |
| March 31, 2024 | 15.15B |
| December 31, 2023 | 15.05B |
| September 30, 2023 | 14.32B |
| June 30, 2023 | 14.41B |
| March 31, 2023 | 14.47B |
| December 31, 2022 | 14.51B |
| September 30, 2022 | 15.52B |
| June 30, 2022 | 15.41B |
| March 31, 2022 | 14.95B |
| December 31, 2021 | 14.53B |
| September 30, 2021 | 13.80B |
| June 30, 2021 | 13.20B |
| March 31, 2021 | 12.62B |
| December 31, 2020 | 12.02B |
| September 30, 2020 | 9.325B |
| June 30, 2020 | 11.01B |
| Date | Value |
|---|---|
| March 31, 2020 | 10.93B |
| December 31, 2019 | 11.46B |
| September 30, 2019 | 13.38B |
| June 30, 2019 | 11.39B |
| March 31, 2019 | 11.39B |
| December 31, 2018 | 10.56B |
| September 30, 2018 | 10.92B |
| June 30, 2018 | 10.96B |
| March 31, 2018 | 10.63B |
| December 31, 2017 | 10.42B |
| September 30, 2017 | 9.458B |
| June 30, 2017 | 9.079B |
| March 31, 2017 | 9.045B |
| December 31, 2016 | 9.005B |
| September 30, 2016 | 9.229B |
| June 30, 2016 | 9.214B |
| March 31, 2016 | 9.087B |
| December 31, 2015 | 9.052B |
| September 30, 2015 | 8.827B |
| June 30, 2015 | 8.697B |
| March 31, 2015 | 8.548B |
| December 31, 2014 | 8.501B |
| September 30, 2014 | 8.312B |
| June 30, 2014 | 8.309B |
| March 31, 2014 | 8.254B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 14.60B |
| Merck & Co., Inc. | 27.26B |
| Pfizer Inc. | 10.82B |
| Bristol Myers Squibb Co. | 9.548B |
| Liquidia Corp. | 54.95M |